Sean Gardner
Analyst
UBS
Equibles does not estimate personal net worth.
About Sean Gardner
Sean Gardner is recorded as Analyst at UBS. Sean Gardner has spoken on 2 earnings calls across 2 companies, most recently for 10x Genomics, Inc. on November 5, 2026. Those appearances were for 10x Genomics, Inc. (TXG) and Maravai Lifesciences Holdings, Inc. (MRVI). The companies whose calls Sean Gardner spoke on are classified in the Healthcare sector.
Sean Gardner on recent calls
“Just wanted to go back to spatial consumables. So it grew 16% again in Q3, 16% in Q2 as well. And I know you kind of previously characterized Q3 as the peak of the ATERRA-related transition.”
“I had a quick question on ModTail again. So, you know, mentioned adoption has grown to over 180 customers. GMP launch remains on track for your end. You mentioned last quarter that a few customers had already requested GMP material.”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current